Immunomedics Inc. (IMMU)

13.24
0.19 1.46
NASDAQ : Health Technology
Prev Close 13.05
Open 13.19
Day Low/High 12.96 / 13.47
52 Wk Low/High 11.55 / 27.33
Volume 1.70M
Avg Volume 2.80M
Exchange NASDAQ
Shares Outstanding 191.54M
Market Cap 2.37B
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline In Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc.

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline In Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP alerts Immunomedics, Inc. (NASDAQ: IMMU) ("Immunomedics") investors that two securities fraud class action lawsuits have been filed in the United States District Court for the District of New Jersey (the...

Robbins Geller Rudman & Dowd LLP Announces A Securities Case Has Been Filed On Behalf Of Purchasers Of Immunomedics, Inc. Securities

Robbins Geller Rudman & Dowd LLP Announces A Securities Case Has Been Filed On Behalf Of Purchasers Of Immunomedics, Inc. Securities

Robbins Geller Rudman & Dowd LLP announces that a securities class action case has been filed on behalf of purchasers of Immunomedics, Inc.

IMMUNOMEDICS SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

IMMUNOMEDICS SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Immunomedics, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Immunomedics, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Immunomedics, Inc.

IMMUNOMEDICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Immunomedics, Inc. To Contact The Firm

IMMUNOMEDICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Immunomedics, Inc. To Contact The Firm

NEW YORK, Jan. 30, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Immunomedics, Inc.

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against Immunomedics, Inc.

Scott Scott Attorneys At Law LLP Reminds Investors Of Securities Class Action Against Immunomedics, Inc.

NEW YORK, Jan. 30, 2019 /PRNewswire/ --  Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against Immunomedics, Inc.

IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

NEW ORLEANS, Jan. 25, 2019 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics, Inc.

IMMU CLASS ACTION: Rosen Law Firm Announces Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU

IMMU CLASS ACTION: Rosen Law Firm Announces Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU

NEW YORK, Jan. 25, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a lawsuit on behalf of purchasers of the securities of Immunomedics, Inc.

Johnson Fistel, LLP Notifies Investors Of Class Actions Against Sogou Inc., Immunomedics, Inc., And Ternium S.A.; Investors Encouraged To Contact Firm

Johnson Fistel, LLP Notifies Investors Of Class Actions Against Sogou Inc., Immunomedics, Inc., And Ternium S.A.; Investors Encouraged To Contact Firm

SAN DIEGO, Jan. 12, 2019 Johnson Fistel, LLP announces that class actions have commenced on behalf of shareholders of the following companies: Sogou Inc.

RM LAW Announces Class Action Lawsuit Against Immunomedics, Inc.

RM LAW Announces Class Action Lawsuit Against Immunomedics, Inc.

BERWYN, Pa., Jan.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Immunomedics, Inc.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Immunomedics, Inc.

Law Offices of Howard G. Smith reminds investors of the February 25, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Immunomedics, Inc.

IMMU LOSS NOTICE: Rosen Law Firm Reminds Immunomedics, Inc. Investors Of Deadline In Case Seeking To Recover Investor Losses - IMMU

IMMU LOSS NOTICE: Rosen Law Firm Reminds Immunomedics, Inc. Investors Of Deadline In Case Seeking To Recover Investor Losses - IMMU

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Immunomedics, Inc.

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc.

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against Immunomedics, Inc.

Investor Alert: Kaplan Fox Announces Investigation Of Immunomedics, Inc.

Investor Alert: Kaplan Fox Announces Investigation Of Immunomedics, Inc.

NEW YORK, Jan. 8, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( www.

IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

NEW ORLEANS, Jan. 4, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.

Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Immunomedics, Inc. Investors

Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Immunomedics, Inc. Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Immunomedics, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against Immunomedics, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against Immunomedics, Inc.

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against Immunomedics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Immunomedics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Immunomedics, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Immunomedics, Inc.

Immunomedics Class Action Lawsuit: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Immunomedics, Inc. - IMMU

Immunomedics Class Action Lawsuit: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Immunomedics, Inc. - IMMU

NEW YORK, Dec. 27, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Immunomedics,...

Block & Leviton LLP Files Securities Class Action Against Immunomedics, Inc. ("IMMU"); Investors Are Encouraged To Contact The Firm

Block & Leviton LLP Files Securities Class Action Against Immunomedics, Inc. ("IMMU"); Investors Are Encouraged To Contact The Firm

BOSTON, Dec. 27, 2018 /PRNewswire/ -- Block & Leviton LLP ( www.

IMMUNOMEDICS LOSSES ALERT: BERNSTEIN LIEBHARD LLP ANNOUNCES INVESTIGATION OF IMMUNOMEDICS, INC. - IMMU

IMMUNOMEDICS LOSSES ALERT: BERNSTEIN LIEBHARD LLP ANNOUNCES INVESTIGATION OF IMMUNOMEDICS, INC. - IMMU

NEW YORK, Dec. 21, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Immunomedics, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Immunomedics Inc. - IMMU

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Immunomedics Inc. - IMMU

NEW YORK, Dec. 20, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immunomedics Inc.

Noteworthy Tuesday Option Activity: IMMU, KODK, APTI

Noteworthy Tuesday Option Activity: IMMU, KODK, APTI

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Immunomedics, Inc. , where a total volume of 13,064 contracts has been traded thus far today, a contract volume which is representative of approximately 1.3 million underlying shares (given that every 1 contract represents 100 underlying shares).

Interesting IMMU Put And Call Options For December 21st

Interesting IMMU Put And Call Options For December 21st

Investors in Immunomedics, Inc. saw new options begin trading this week, for the December 21st expiration.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BLFS, BOSC, HESM, PLAB, PSEC Downgrades: CREE, IMMU Initiations: FPH, RNGR Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: D+ (Sell)